Structure

Physi-Chem Properties

Molecular Weight:  444.29
Volume:  468.808
LogP:  4.807
LogD:  4.102
LogS:  -4.633
# Rotatable Bonds:  2
TPSA:  79.9
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.529
Synthetic Accessibility Score:  4.945
Fsp3:  0.815
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.878
MDCK Permeability:  2.4978169676614925e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.07
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.02
30% Bioavailability (F30%):  0.95

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.362
Plasma Protein Binding (PPB):  94.68463897705078%
Volume Distribution (VD):  1.351
Pgp-substrate:  6.6950812339782715%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.188
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.615
CYP2C9-inhibitor:  0.29
CYP2C9-substrate:  0.497
CYP2D6-inhibitor:  0.03
CYP2D6-substrate:  0.389
CYP3A4-inhibitor:  0.204
CYP3A4-substrate:  0.354

ADMET: Excretion

Clearance (CL):  7.977
Half-life (T1/2):  0.11

ADMET: Toxicity

hERG Blockers:  0.047
Human Hepatotoxicity (H-HT):  0.242
Drug-inuced Liver Injury (DILI):  0.072
AMES Toxicity:  0.018
Rat Oral Acute Toxicity:  0.923
Maximum Recommended Daily Dose:  0.874
Skin Sensitization:  0.35
Carcinogencity:  0.309
Eye Corrosion:  0.022
Eye Irritation:  0.265
Respiratory Toxicity:  0.934

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC165250

Natural Product ID:  NPC165250
Common Name*:   Sesterstatin 7
IUPAC Name:   [(4S,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1-oxo-4,5,5a,6,7,7a,9,10,11,11b,12,13-dodecahydro-3H-phenanthro[2,1-e][2]benzofuran-4-yl] acetate
Synonyms:   16-Beta-Acetoxyscalarolide
Standard InCHIKey:  LOCDSBKFSVHNIV-XPSVZDKBSA-N
Standard InCHI:  InChI=1S/C27H40O5/c1-15(28)32-17-12-20-26(5)11-8-18-24(2,3)9-7-10-25(18,4)19(26)13-21(29)27(20,6)22-16(17)14-31-23(22)30/h17-21,29H,7-14H2,1-6H3/t17-,18-,19+,20-,21+,25-,26+,27+/m0/s1
SMILES:  CC(=O)O[C@H]1C[C@@H]2[C@](C3=C1COC3=O)(C)[C@H](O)C[C@H]1[C@@]2(C)CC[C@@H]2[C@]1(C)CCCC2(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL456095
PubChem CID:   5324503
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001552] Sesterterpenoids
          • [CHEMONTID:0002883] Scalarane sesterterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Red Sea n.a. PMID[11809054]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Indian Ocean n.a. PMID[16124771]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Red Sea n.a. PMID[16378375]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[9584401]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Maldives n.a. PMID[9873492]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis Inhibition = 63.0 % PMID[449405]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC165250 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9574 High Similarity NPC175351
0.9574 High Similarity NPC132753
0.9574 High Similarity NPC121402
0.9574 High Similarity NPC151681
0.9574 High Similarity NPC224356
0.9495 High Similarity NPC325054
0.9485 High Similarity NPC471208
0.9468 High Similarity NPC154526
0.9468 High Similarity NPC472363
0.9468 High Similarity NPC472362
0.9208 High Similarity NPC31522
0.9109 High Similarity NPC275539
0.9109 High Similarity NPC189075
0.9109 High Similarity NPC90946
0.9109 High Similarity NPC300614
0.901 High Similarity NPC110496
0.899 High Similarity NPC476081
0.89 High Similarity NPC159533
0.88 High Similarity NPC295791
0.8762 High Similarity NPC194951
0.8762 High Similarity NPC12046
0.8713 High Similarity NPC478057
0.8713 High Similarity NPC120321
0.8713 High Similarity NPC254202
0.8679 High Similarity NPC25909
0.8679 High Similarity NPC157441
0.8641 High Similarity NPC67321
0.8641 High Similarity NPC187435
0.8614 High Similarity NPC469606
0.8614 High Similarity NPC31058
0.8614 High Similarity NPC273005
0.86 High Similarity NPC47024
0.8586 High Similarity NPC51499
0.8585 High Similarity NPC277769
0.8544 High Similarity NPC34768
0.8544 High Similarity NPC469607
0.8529 High Similarity NPC95899
0.8515 High Similarity NPC471412
0.8515 High Similarity NPC471075
0.85 High Similarity NPC325229
0.85 High Similarity NPC216478
0.85 High Similarity NPC275086
0.8485 Intermediate Similarity NPC134072
0.8485 Intermediate Similarity NPC234993
0.8476 Intermediate Similarity NPC299590
0.8462 Intermediate Similarity NPC143609
0.8447 Intermediate Similarity NPC222161
0.8431 Intermediate Similarity NPC137430
0.8431 Intermediate Similarity NPC162973
0.8416 Intermediate Similarity NPC471413
0.8416 Intermediate Similarity NPC476299
0.8416 Intermediate Similarity NPC251680
0.8416 Intermediate Similarity NPC476767
0.8416 Intermediate Similarity NPC474012
0.8411 Intermediate Similarity NPC269530
0.8411 Intermediate Similarity NPC470063
0.8411 Intermediate Similarity NPC90952
0.8411 Intermediate Similarity NPC4573
0.8396 Intermediate Similarity NPC472666
0.8384 Intermediate Similarity NPC157686
0.8384 Intermediate Similarity NPC276110
0.8384 Intermediate Similarity NPC259042
0.8381 Intermediate Similarity NPC306265
0.8381 Intermediate Similarity NPC469916
0.8381 Intermediate Similarity NPC472439
0.8367 Intermediate Similarity NPC472640
0.8367 Intermediate Similarity NPC472641
0.8367 Intermediate Similarity NPC139692
0.8365 Intermediate Similarity NPC111952
0.8365 Intermediate Similarity NPC478208
0.835 Intermediate Similarity NPC474822
0.835 Intermediate Similarity NPC36688
0.835 Intermediate Similarity NPC99266
0.835 Intermediate Similarity NPC8196
0.835 Intermediate Similarity NPC112009
0.8333 Intermediate Similarity NPC235142
0.8318 Intermediate Similarity NPC469655
0.8318 Intermediate Similarity NPC474846
0.8318 Intermediate Similarity NPC469656
0.8317 Intermediate Similarity NPC478056
0.8316 Intermediate Similarity NPC250981
0.8302 Intermediate Similarity NPC476759
0.8302 Intermediate Similarity NPC112457
0.83 Intermediate Similarity NPC7124
0.8286 Intermediate Similarity NPC473586
0.8286 Intermediate Similarity NPC179380
0.8286 Intermediate Similarity NPC469318
0.8286 Intermediate Similarity NPC302788
0.8286 Intermediate Similarity NPC475570
0.8286 Intermediate Similarity NPC473173
0.8283 Intermediate Similarity NPC469596
0.8283 Intermediate Similarity NPC148000
0.8283 Intermediate Similarity NPC105490
0.8283 Intermediate Similarity NPC91010
0.8283 Intermediate Similarity NPC225474
0.8273 Intermediate Similarity NPC134430
0.8273 Intermediate Similarity NPC473968
0.8273 Intermediate Similarity NPC55296
0.8265 Intermediate Similarity NPC477574
0.8265 Intermediate Similarity NPC235704
0.8265 Intermediate Similarity NPC41239
0.8257 Intermediate Similarity NPC110861
0.8252 Intermediate Similarity NPC476890
0.8252 Intermediate Similarity NPC58329
0.8252 Intermediate Similarity NPC476769
0.8241 Intermediate Similarity NPC476163
0.8241 Intermediate Similarity NPC42658
0.8235 Intermediate Similarity NPC477971
0.8235 Intermediate Similarity NPC228251
0.8235 Intermediate Similarity NPC20113
0.8235 Intermediate Similarity NPC477968
0.8235 Intermediate Similarity NPC201406
0.8235 Intermediate Similarity NPC117685
0.8235 Intermediate Similarity NPC477972
0.8235 Intermediate Similarity NPC161527
0.8235 Intermediate Similarity NPC307954
0.8235 Intermediate Similarity NPC219285
0.8229 Intermediate Similarity NPC471779
0.8224 Intermediate Similarity NPC478209
0.8218 Intermediate Similarity NPC91695
0.8218 Intermediate Similarity NPC476879
0.8218 Intermediate Similarity NPC473963
0.8218 Intermediate Similarity NPC70145
0.8218 Intermediate Similarity NPC476878
0.8214 Intermediate Similarity NPC251226
0.8214 Intermediate Similarity NPC268530
0.8214 Intermediate Similarity NPC154491
0.8208 Intermediate Similarity NPC475263
0.8208 Intermediate Similarity NPC473483
0.8208 Intermediate Similarity NPC476479
0.8208 Intermediate Similarity NPC476765
0.82 Intermediate Similarity NPC183012
0.82 Intermediate Similarity NPC474727
0.819 Intermediate Similarity NPC88349
0.819 Intermediate Similarity NPC220217
0.819 Intermediate Similarity NPC119855
0.819 Intermediate Similarity NPC478052
0.8182 Intermediate Similarity NPC229281
0.8182 Intermediate Similarity NPC7349
0.8182 Intermediate Similarity NPC110022
0.8182 Intermediate Similarity NPC99653
0.8182 Intermediate Similarity NPC268954
0.8182 Intermediate Similarity NPC44170
0.8182 Intermediate Similarity NPC199543
0.8173 Intermediate Similarity NPC324001
0.8173 Intermediate Similarity NPC180204
0.8173 Intermediate Similarity NPC476889
0.8173 Intermediate Similarity NPC95585
0.8173 Intermediate Similarity NPC282233
0.8173 Intermediate Similarity NPC45897
0.8163 Intermediate Similarity NPC472642
0.8163 Intermediate Similarity NPC78973
0.8155 Intermediate Similarity NPC93744
0.8155 Intermediate Similarity NPC11974
0.8155 Intermediate Similarity NPC97435
0.8155 Intermediate Similarity NPC303559
0.8155 Intermediate Similarity NPC476888
0.8155 Intermediate Similarity NPC63249
0.8142 Intermediate Similarity NPC4021
0.8142 Intermediate Similarity NPC67569
0.8142 Intermediate Similarity NPC159456
0.8137 Intermediate Similarity NPC475876
0.8137 Intermediate Similarity NPC164349
0.8137 Intermediate Similarity NPC222303
0.8137 Intermediate Similarity NPC234617
0.8137 Intermediate Similarity NPC260149
0.8137 Intermediate Similarity NPC124703
0.8137 Intermediate Similarity NPC58942
0.8131 Intermediate Similarity NPC5475
0.8131 Intermediate Similarity NPC472216
0.8131 Intermediate Similarity NPC284828
0.8131 Intermediate Similarity NPC173905
0.8131 Intermediate Similarity NPC478210
0.8125 Intermediate Similarity NPC476529
0.8125 Intermediate Similarity NPC473636
0.8125 Intermediate Similarity NPC230513
0.8125 Intermediate Similarity NPC475041
0.8125 Intermediate Similarity NPC475775
0.8125 Intermediate Similarity NPC42673
0.8125 Intermediate Similarity NPC77689
0.8119 Intermediate Similarity NPC29952
0.8119 Intermediate Similarity NPC116457
0.8119 Intermediate Similarity NPC165632
0.8119 Intermediate Similarity NPC476327
0.8119 Intermediate Similarity NPC476318
0.8119 Intermediate Similarity NPC473964
0.8119 Intermediate Similarity NPC327179
0.8119 Intermediate Similarity NPC93245
0.8119 Intermediate Similarity NPC242848
0.8119 Intermediate Similarity NPC202833
0.8113 Intermediate Similarity NPC301666
0.8108 Intermediate Similarity NPC475809
0.8108 Intermediate Similarity NPC473590
0.8108 Intermediate Similarity NPC474483
0.8105 Intermediate Similarity NPC32223
0.81 Intermediate Similarity NPC191412
0.81 Intermediate Similarity NPC57117
0.81 Intermediate Similarity NPC474554
0.81 Intermediate Similarity NPC159365
0.81 Intermediate Similarity NPC471720

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC165250 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.85 High Similarity NPD7638 Approved
0.8476 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.8416 Intermediate Similarity NPD7639 Approved
0.8416 Intermediate Similarity NPD7640 Approved
0.8396 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.8252 Intermediate Similarity NPD7632 Discontinued
0.8113 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD7902 Approved
0.7921 Intermediate Similarity NPD7748 Approved
0.79 Intermediate Similarity NPD7515 Phase 2
0.787 Intermediate Similarity NPD6686 Approved
0.7788 Intermediate Similarity NPD7115 Discovery
0.7745 Intermediate Similarity NPD7900 Approved
0.7745 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD7507 Approved
0.7647 Intermediate Similarity NPD6399 Phase 3
0.7636 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4225 Approved
0.7549 Intermediate Similarity NPD8035 Phase 2
0.7549 Intermediate Similarity NPD8034 Phase 2
0.7523 Intermediate Similarity NPD7128 Approved
0.7523 Intermediate Similarity NPD6402 Approved
0.7523 Intermediate Similarity NPD5739 Approved
0.7523 Intermediate Similarity NPD6675 Approved
0.7521 Intermediate Similarity NPD7319 Approved
0.7478 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7477 Intermediate Similarity NPD6373 Approved
0.7477 Intermediate Similarity NPD6372 Approved
0.7414 Intermediate Similarity NPD7328 Approved
0.7414 Intermediate Similarity NPD7327 Approved
0.74 Intermediate Similarity NPD3618 Phase 1
0.7387 Intermediate Similarity NPD6881 Approved
0.7387 Intermediate Similarity NPD6899 Approved
0.7387 Intermediate Similarity NPD7320 Approved
0.7373 Intermediate Similarity NPD8033 Approved
0.7364 Intermediate Similarity NPD6008 Approved
0.735 Intermediate Similarity NPD7516 Approved
0.7347 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD6650 Approved
0.7345 Intermediate Similarity NPD6649 Approved
0.73 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD1694 Approved
0.7297 Intermediate Similarity NPD5697 Approved
0.7297 Intermediate Similarity NPD6412 Phase 2
0.7297 Intermediate Similarity NPD5701 Approved
0.7288 Intermediate Similarity NPD8294 Approved
0.7288 Intermediate Similarity NPD8377 Approved
0.7281 Intermediate Similarity NPD6053 Discontinued
0.7257 Intermediate Similarity NPD6883 Approved
0.7257 Intermediate Similarity NPD7102 Approved
0.7257 Intermediate Similarity NPD7290 Approved
0.7255 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD8328 Phase 3
0.7232 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7227 Intermediate Similarity NPD8379 Approved
0.7227 Intermediate Similarity NPD8378 Approved
0.7227 Intermediate Similarity NPD8335 Approved
0.7227 Intermediate Similarity NPD8296 Approved
0.7227 Intermediate Similarity NPD8380 Approved
0.7217 Intermediate Similarity NPD8133 Approved
0.7196 Intermediate Similarity NPD6084 Phase 2
0.7196 Intermediate Similarity NPD6083 Phase 2
0.7193 Intermediate Similarity NPD6869 Approved
0.7193 Intermediate Similarity NPD6617 Approved
0.7193 Intermediate Similarity NPD8130 Phase 1
0.7193 Intermediate Similarity NPD6847 Approved
0.7184 Intermediate Similarity NPD5328 Approved
0.7168 Intermediate Similarity NPD6012 Approved
0.7168 Intermediate Similarity NPD6013 Approved
0.7168 Intermediate Similarity NPD6014 Approved
0.713 Intermediate Similarity NPD8297 Approved
0.713 Intermediate Similarity NPD6882 Approved
0.7115 Intermediate Similarity NPD6698 Approved
0.7115 Intermediate Similarity NPD46 Approved
0.7113 Intermediate Similarity NPD6118 Approved
0.7113 Intermediate Similarity NPD6115 Approved
0.7113 Intermediate Similarity NPD6114 Approved
0.7113 Intermediate Similarity NPD6697 Approved
0.708 Intermediate Similarity NPD6011 Approved
0.7069 Intermediate Similarity NPD4632 Approved
0.7059 Intermediate Similarity NPD7521 Approved
0.7059 Intermediate Similarity NPD7334 Approved
0.7059 Intermediate Similarity NPD6684 Approved
0.7059 Intermediate Similarity NPD5330 Approved
0.7059 Intermediate Similarity NPD6409 Approved
0.7059 Intermediate Similarity NPD7146 Approved
0.7048 Intermediate Similarity NPD6079 Approved
0.7043 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4755 Approved
0.703 Intermediate Similarity NPD4786 Approved
0.7019 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7736 Approved
0.701 Intermediate Similarity NPD6116 Phase 1
0.7 Intermediate Similarity NPD3667 Approved
0.7 Intermediate Similarity NPD6319 Approved
0.6981 Remote Similarity NPD5778 Approved
0.6981 Remote Similarity NPD4202 Approved
0.6981 Remote Similarity NPD5779 Approved
0.6972 Remote Similarity NPD5696 Approved
0.6944 Remote Similarity NPD4697 Phase 3
0.6942 Remote Similarity NPD7503 Approved
0.6937 Remote Similarity NPD5211 Phase 2
0.6923 Remote Similarity NPD6672 Approved
0.6923 Remote Similarity NPD6903 Approved
0.6923 Remote Similarity NPD5737 Approved
0.6911 Remote Similarity NPD7492 Approved
0.6909 Remote Similarity NPD4696 Approved
0.6909 Remote Similarity NPD5285 Approved
0.6909 Remote Similarity NPD5286 Approved
0.6909 Remote Similarity NPD4700 Approved
0.6907 Remote Similarity NPD6117 Approved
0.6891 Remote Similarity NPD6009 Approved
0.6887 Remote Similarity NPD6411 Approved
0.6869 Remote Similarity NPD7645 Phase 2
0.6863 Remote Similarity NPD3665 Phase 1
0.6863 Remote Similarity NPD3133 Approved
0.6863 Remote Similarity NPD3666 Approved
0.686 Remote Similarity NPD6054 Approved
0.686 Remote Similarity NPD6059 Approved
0.6855 Remote Similarity NPD6616 Approved
0.6852 Remote Similarity NPD5695 Phase 3
0.6852 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6847 Remote Similarity NPD5344 Discontinued
0.6829 Remote Similarity NPD7604 Phase 2
0.6827 Remote Similarity NPD3573 Approved
0.6814 Remote Similarity NPD5141 Approved
0.681 Remote Similarity NPD6371 Approved
0.6807 Remote Similarity NPD6274 Approved
0.6803 Remote Similarity NPD5983 Phase 2
0.6803 Remote Similarity NPD8513 Phase 3
0.6803 Remote Similarity NPD8515 Approved
0.6803 Remote Similarity NPD8517 Approved
0.6803 Remote Similarity NPD8516 Approved
0.68 Remote Similarity NPD8293 Discontinued
0.68 Remote Similarity NPD7078 Approved
0.6789 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6789 Remote Similarity NPD5222 Approved
0.6789 Remote Similarity NPD5221 Approved
0.6786 Remote Similarity NPD5224 Approved
0.6786 Remote Similarity NPD5226 Approved
0.6786 Remote Similarity NPD4633 Approved
0.6786 Remote Similarity NPD5225 Approved
0.6777 Remote Similarity NPD7101 Approved
0.6777 Remote Similarity NPD7100 Approved
0.6748 Remote Similarity NPD6370 Approved
0.6731 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6729 Remote Similarity NPD5693 Phase 1
0.6729 Remote Similarity NPD7637 Suspended
0.6727 Remote Similarity NPD5173 Approved
0.6726 Remote Similarity NPD5174 Approved
0.6726 Remote Similarity NPD5175 Approved
0.672 Remote Similarity NPD6336 Discontinued
0.6701 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6699 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6698 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6698 Remote Similarity NPD4753 Phase 2
0.6698 Remote Similarity NPD6101 Approved
0.6697 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6696 Remote Similarity NPD5223 Approved
0.6694 Remote Similarity NPD6335 Approved
0.6667 Remote Similarity NPD6015 Approved
0.6667 Remote Similarity NPD4634 Approved
0.6667 Remote Similarity NPD6016 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD6908 Approved
0.6667 Remote Similarity NPD6909 Approved
0.6636 Remote Similarity NPD5785 Approved
0.6634 Remote Similarity NPD7525 Registered
0.6613 Remote Similarity NPD5988 Approved
0.6612 Remote Similarity NPD6317 Approved
0.661 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6609 Remote Similarity NPD4768 Approved
0.6609 Remote Similarity NPD4767 Approved
0.6607 Remote Similarity NPD6648 Approved
0.66 Remote Similarity NPD3617 Approved
0.6589 Remote Similarity NPD7260 Phase 2
0.6579 Remote Similarity NPD4754 Approved
0.6574 Remote Similarity NPD5281 Approved
0.6574 Remote Similarity NPD5284 Approved
0.656 Remote Similarity NPD6067 Discontinued
0.6557 Remote Similarity NPD6313 Approved
0.6557 Remote Similarity NPD6314 Approved
0.6552 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6545 Remote Similarity NPD4629 Approved
0.6545 Remote Similarity NPD5210 Approved
0.6542 Remote Similarity NPD6673 Approved
0.6542 Remote Similarity NPD6051 Approved
0.6542 Remote Similarity NPD6080 Approved
0.6542 Remote Similarity NPD6904 Approved
0.6538 Remote Similarity NPD3668 Phase 3
0.6538 Remote Similarity NPD6845 Suspended
0.6532 Remote Similarity NPD6921 Approved
0.6532 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6496 Remote Similarity NPD4730 Approved
0.6496 Remote Similarity NPD4729 Approved
0.6496 Remote Similarity NPD5128 Approved
0.6486 Remote Similarity NPD7614 Phase 1
0.6481 Remote Similarity NPD7838 Discovery
0.6471 Remote Similarity NPD4695 Discontinued
0.6465 Remote Similarity NPD3703 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data